Details

NameSymbolSector
GLENMARK PHARMACEUTICALS LTDGLENMARKPharmaceuticals
Open
2320
High
2341.6
Low
2307.2
Close
2318.4
Volume
629081
Exchange
nse
Time
14-Aug-2026

Outlook

Score:  

3.25

Rating:  

FAIR

Candlestick Pattern

Candle pattern of Glenmark Pharmaceuticals is  
High Wave
Estimated Stoploss of Glenmark Pharmaceuticals is ₹  
2341.6
Glenmark Pharmaceuticals has a  
Bearishℹ
 pattern. 
Formation of  
High Wave
 candle pattern indicates the trend direction of Glenmark Pharmaceuticals is  
Unpredictableℹ
. 

Trend

Glenmark Pharmaceuticals is in  
Sideways trendℹ
. 
Price of Glenmark Pharmaceuticals is  
Upℹ
 by  

3.64

%. 
Target
Buy @ 

2111.59

Sell @ 

2381.73

Current @ 

2318.4

Volume

The trade volumes of Glenmark Pharmaceuticals have been  
Underperformingℹ
Though the volume trend for Glenmark Pharmaceuticals appears  
Bullishℹ
 the participants seem to be  
Weak Buyersℹ
The trade volume of Glenmark Pharmaceuticals is  

Down

 by  

5.55

% 

Valuation

The current market price of Glenmark Pharmaceuticals is  
Overvaluedℹ

Financials

Balance
With total liablities and shareholder equity worth ₹ 16049cr and total assets worth ₹ 16049cr, the balance sheet of Glenmark Pharmaceuticals is:  
Balancedℹ
. 
Cashflow
Glenmark Pharmaceuticals has  
Maintainedℹ
 cash flow because there is  

Surplus

 of  

₹ 17cr

. It is  
Downℹ
 by  

92.09

%. 

(*Mar 2025)

49.49% i.e. ₹ 827cr spent in operatingℹ
0.12% i.e. ₹ 2cr earned in investingℹ
47.1% i.e. ₹ 787cr earned in financingℹ
3.29% i.e. ₹ 55cr earned in otherℹ
Glenmark Pharmaceuticals has  
Excellentℹ
 cash flow because there is  

Surplus

 of  

₹ 215cr

. It is  
Upℹ
 by  

571.88

%. 

(*Mar 2024)

2.98% i.e. ₹ 265cr spent in operatingℹ
51.21% i.e. ₹ 4560cr earned in investingℹ
43.86% i.e. ₹ 3906cr spent in financingℹ
1.95% i.e. ₹ 174cr spent in otherℹ
Income
The income of Glenmark Pharmaceuticals is  

₹ 6247cr

 and  

Profit

 is :  

₹ 610cr

(*Sep 2025)

Glenmark Pharmaceuticals Profit is up by:  

1226.09

% and Income is Up by:  

89.88

% 

(*Sep 2025)

The income of Glenmark Pharmaceuticals is  

₹ 3290cr

 and  

Profit

 is :  

₹ 46cr

(*Jun 2025)

Glenmark Pharmaceuticals Profit is up by:  

1050

% and Income is Up by:  

0.7

% 

(*Jun 2025)

The income of Glenmark Pharmaceuticals is  

₹ 3267cr

 and  

Profit

 is :  

₹ 4cr

(*Mar 2025)

Glenmark Pharmaceuticals Profit is down by:  

98.85

% and Income is Down by:  

4.42

% 

(*Mar 2025)

By using this site you agree to the use of cookies to deliver a better site experience.